U.S. market Closed. Opens in 18 hours 55 minutes

LIXTW | Lixte Biotechnology Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A
Operating Expenses5.09M6.31M6.72M3.27M2.49M
Selling, General & Admin4.19M4.96M4.98M2.01M1.67M
Research & Development898.10K1.35M1.74M1.22M820.91K
Other Operating ExpensesN/AN/AN/A33.81KN/A
Operating Income-5.09M-6.31M-6.72M-3.27M-2.49M
Other Expenses / Income3.21K-1.05K-7.95K1.56K49.72K
Before Tax Income-5.09M-6.31M-6.73M-3.26M-2.44M
Income Tax ExpensesN/A-7.82K6.79K-1.56K-49.72K
Net Income-5.09M-6.30M-6.74M-3.26M-2.39M
Interest ExpensesN/A8.88K7.41K3.67KN/A
Basic Shares Outstanding1.91M158.20K1.35M1.13M1.12M
Diluted Shares Outstanding1.92M158.20K1.35M1.13M1.12M
EBITDA3.21K-1.05K-7.95K1.56K-2.49M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-5.09M-6.30M-6.72M-3.26M-2.44M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙